Clinical, hormonal, and molecular-genetic characteristics of three cases of 46XY disorder of sex development caused by type II 5-alpha reductase deficiency
Author(s) -
А. А. Колодкина,
M E Karmanov,
Н. Ю. Калинченко,
Alexander N. Nizhnik,
M A Nokel',
А. К. Файзулин,
Anatoly Tiulpakov
Publication year - 2010
Publication title -
problems of endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.124
H-Index - 5
eISSN - 2308-1430
pISSN - 0375-9660
DOI - 10.14341/probl201056334-40
Subject(s) - disorders of sex development , androgen , alpha (finance) , endocrinology , androgen deficiency , androgen insensitivity syndrome , sexual differentiation , hormone , reductase , medicine , inefficiency , biology , gene , enzyme , genetics , biochemistry , clinical psychology , androgen receptor , cancer , construct validity , microeconomics , prostate cancer , economics , psychometrics
Deficiency of type II 5-alpha reductase (5-ARII) is known to be responsible for abnormal sexual differentiation in boys. Of primary importance is differential diagnosis between this condition and incomplete form of androgen resistance. In the latter case, adaptation to male gender is highly undesirable because of inefficiency of androgen therapy. In contrast, such adaptation is socially justified in patients with type II 5-alpha reductase deficiency; sometimes, it permits to preserve fertility. The cases reported in this paper demonstrate low diagnostic value of the T/DHT ratio (at least as determined by the immunoenzyme assay) and emphasize the necessity of analysis of the SRD5A2 gene in all patients with suspected deficiency of type II 5-alpha reductase.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom